Abstract:ObjectiveThe Consolidated Standards for Reporting of Trials (CONSORT) statement has already proved to be an efficient standard for reporting quality of randomized controlled trials (RCTs). However, most of the Chinese medical journals have not endorsed the CONSORT statement. The current situation about the reporting quality of RCTs in Chinese medical journals is still unclear. The purpose of the study was to evaluate the reporting quality of RCTs on papers published in 5 leading Chinese medical journals.MethodsWe evaluated 232 original RCT papers using a reporting quality scale based on CONSORT statement from 2001 to 2006 in 5 Chinese medical journals (Journal type 1) without adoption of CONSORT and Chinese Journal of Evidence-based Medicine (Journal type 2) which adopted CONSORT in 2004. We measured the inclusion of 26 items for the reporting quality scale and 6 core items of each RCT report, gave score to each item and calculated the total score obtained in each report and the proportion of reports including individual items. The reporting quality of RCT trials from 2001 to 2003 (pre-adoption period) was compared with that from 2004 to 2006 (post-adoption period).ResultsThe average reporting quality of RCTs was moderate (mean score, 15.18), and the mean score of the 6 core items was low (mean score, 1.09) in 5 leading journals. The difference in the total score and the score of the 6 core items between pre-adoption period (2001–2003) and post-adoption period (2004—2006) was statistically significant (P=0.003; P=0.000). Interaction between journal type and period was not significant (F=0.76; P=0.383). We concluded that the change tendency of reporting quality between Journal type 1 and 2 was not different. But as to the core items of sequence concealment and intention-to-treat analysis, the increases were greater for Journal type 2 when evaluated against Journal type 1 (P=0.038; P=0.016).ConclusionThe reporting quality of RCT trials in 5 leading Chinese medical journals is improving. However, the lack of important items in RCT trials remains a serious problem. We recommend the endorsement of the Consolidated Standards for Reporting of Trials statement in Chinese medical journals and the continuing education on evidence-based medicine in China.

Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review

Quality of Reporting in Oncology Randomized Controlled Trials

Quality of Reporting in Surgical Randomized Clinical Trials.

The reporting standards of randomised controlled trials in leading medical journals between 2019 and 2020: a systematic review

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed

Are Reports of Randomized Controlled Trials Improving over Time? A Systematic Review of 284 Articles Published in High-Impact General and Specialized Medical Journals

Methodological Reporting of Randomized Controlled Trials in Major Hepato-Gastroenterology Journals in 2008 and 1998: a Comparative Study

The Quality of Reporting of Randomized Trials Related to Digestive Diseases in 2008 and 1998:A Comparative Study

Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015

Current Situation on the Reporting Quality of Randomized Controlled Trials in 5 Leading Chinese Medical Journals

Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?

Assessing the reporting quality of pediatric neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements

Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria

Evaluating the completeness of the reporting of abstracts since the publication of the CONSORT extension for abstracts: an evaluation of randomized controlled trial in ten nursing journals

Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine

Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis

Quality of reporting and risk of bias: a review of randomised trials in occupational health

Assessment of the Reporting Quality of Ophthalmic Diseases Related Randomized Controlled Trials Published in SCI Journals from Mainland China

Methodology reporting improved over time in 176,469 randomized controlled trials

Quality Assessment of the Reporting of Randomized Controlled Trials Published in the Chinese Journal of Integrated Traditional and Western Medicine with the Revised CONSORT Statement